FDA Information
FDA approved the first drug based on salmon calcitonin, Calcimar®, an injectable form marketed by Rhone-Poulenc Rorer in 1975.
Since then, two drugs made by Novartis and marketed under the trade name Miacalcin® - one injectable form and one administered through a nasal spray - were approved. An oral version of salmon calcitonin is nowadays also available.
Salmon calcitonin is approved only for postmenopausal women who cannot tolerate estrogen, or for whom estrogen is not an option.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?